Literature DB >> 28432546

Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result.

Amanda T Wiggins1, Edward J Pavlik2, Michael A Andrykowski3.   

Abstract

While participation in cancer screening can facilitate early detection and improved prognosis, all screening tests yield some proportion of abnormal test results which are later determined benign. These false positive (FP) results can negatively impact affective, cognitive, and behavioral outcomes. Women participating in an ovarian cancer (OC) screening program receiving an abnormal screening test result (n = 375) were matched with women receiving normal results (n = 375). Both groups completed a baseline and 1- and 4-month follow-up assessments. FP test results were clearly associated with increased cancer-specific distress and increased perceptions of OC risk with more limited evidence for increased perceived positive consequences of screening and increased intentions to participate in future OC screening. FP OC screening test results negatively impact both affective and cognitive outcomes which may serve to reduce motivation to participate in future routine screening. The development and testing of brief, timely interventions to minimize this negative impact is warranted.

Entities:  

Keywords:  Cancer screening; Cancer-specific distress; False-positive; Ovarian cancer; Perceived risk

Mesh:

Year:  2017        PMID: 28432546     DOI: 10.1007/s10865-017-9851-1

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  35 in total

1.  The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

Authors:  R D Hays; J M Woolley
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Changes in cancer worry associated with participation in ovarian cancer screening.

Authors:  M Robyn Andersen; Charles W Drescher; Yingye Zheng; Deborah J Bowen; Susan Wilson; Alicia Young; Martin McIntosh; Barry S Mahony; Kimberly A Lowe; Nicole Urban
Journal:  Psychooncology       Date:  2007-09       Impact factor: 3.894

3.  Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer.

Authors:  M H Antoni; J M Lehman; K M Kilbourn; A E Boyers; J L Culver; S M Alferi; S E Yount; B A McGregor; P L Arena; S D Harris; A A Price; C S Carver
Journal:  Health Psychol       Date:  2001-01       Impact factor: 4.267

Review 4.  Systematic review: the long-term effects of false-positive mammograms.

Authors:  Noel T Brewer; Talya Salz; Sarah E Lillie
Journal:  Ann Intern Med       Date:  2007-04-03       Impact factor: 25.391

5.  Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up.

Authors:  Noah D Kauff; Karen E Hurley; Martee L Hensley; Mark E Robson; Gali Lev; Deborah Goldfrank; Mercedes Castiel; Carol L Brown; Jamie S Ostroff; Lucy E Hann; Kenneth Offit; Richard R Barakat
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

6.  Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS).

Authors:  Kate J Lifford; Lindsay Fraser; Adam N Rosenthal; Mark T Rogers; Deborah Lancastle; Ceri Phelps; Eila K Watson; Alison Clements; Rachel Iredale; Ian Jacobs; Usha Menon; Kate E Brain
Journal:  Gynecol Oncol       Date:  2011-10-15       Impact factor: 5.482

7.  Psychological impact of screening for familial ovarian cancer.

Authors:  F J Wardle; W Collins; A L Pernet; M I Whitehead; T H Bourne; S Campbell
Journal:  J Natl Cancer Inst       Date:  1993-04-21       Impact factor: 13.506

Review 8.  Ultrasound screening for the early detection of ovarian cancer.

Authors:  Paul D DePriest; Christopher P DeSimone
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

9.  Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harm.

Authors:  Kate E Brain; Kate J Lifford; Lindsay Fraser; Adam N Rosenthal; Mark T Rogers; Deborah Lancastle; Ceri Phelps; Eila K Watson; Alison Clements; Usha Menon
Journal:  Gynecol Oncol       Date:  2012-08-31       Impact factor: 5.482

10.  Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).

Authors:  J Barrett; V Jenkins; V Farewell; U Menon; I Jacobs; J Kilkerr; A Ryan; C Langridge; L Fallowfield
Journal:  BJOG       Date:  2014-05-28       Impact factor: 6.531

View more
  3 in total

1.  Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study.

Authors:  Amanda T Wiggins; Edward J Pavlik; Michael A Andrykowski
Journal:  J Behav Med       Date:  2017-10-25

Review 2.  Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening.

Authors:  Michael A Andrykowski
Journal:  Diagnostics (Basel)       Date:  2017-03-08

Review 3.  The half-painted picture: Reviewing the mental health impacts of cancer screening.

Authors:  Lauren P Wadsworth; Inga Wessman; Andri Steinþór Björnsson; Gudbjorg Jonsdottir; Sigurður Yngvi Kristinsson
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.